Canada: Medical lab chains will combine forces, big bills to come for government
The Competition Bureau has announced that it will not take action to block two of British Columbia’s largest private medical chains from merging. LifeLabs plans to guy BC Biomedical, an acquisition that will mean LifeLab will now bill nearly $200 million a year to the government’s Medical Service Plan for state-funded testing. Despite concerns over the merger, the Medical Services Commission has reportedly approved for LifeLabs to run the former BC Biomedical labs. The parties expect to close the deal in April.
Featured News
President Trump’s Media Investments Stir Ethics Questions After Netflix–Warner Bros. Deal
Jan 19, 2026 by
CPI
Elon Musk Seeks Billions in Damages From OpenAI and Microsoft as Legal Fight Heads to Trial
Jan 19, 2026 by
CPI
Italy’s Leonardo Chairman Floats Possible Merger With Fincantieri
Jan 19, 2026 by
CPI
Spanish Competition Authority Clears Naver’s Takeover of Wallapop
Jan 19, 2026 by
CPI
As Companies Move From AI Testing to Implementation, Compliance Takes Center Stage
Jan 19, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – CRESSE Insights
Dec 16, 2025 by
CPI
Learning from Divergence: The Role of Cross-Country Comparisons in the Evaluation of the DMA
Dec 16, 2025 by
Federico Bruni
New Regulatory Tools for the EU Foreign Direct Investment Screening and Foreign Subsidies Regulation
Dec 16, 2025 by
Ioannis Kokkoris
“Suite Dreams”: Market Definition and Complementarity in the Digital Age
Dec 16, 2025 by
Romain Bizet & Matteo Foschi
The Interaction Between Competition Policy and Consumer Protection: Institutional Design, Behavioral Insights, and Emerging Challenges in Digital Markets
Dec 16, 2025 by
Alessandra Tonazzi